Clinical Trials Logo

Filter by:
NCT ID: NCT03581604 Recruiting - Allergy Drug Clinical Trials

De-labeling of Patients With False Diagnosis of Penicillin Allergy

Start date: September 13, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to estimate the prevalence of penicillin allergy, evaluate the diagnostic value of the allergologic work-up used in the study, and the health effects of penicillin allergy.

NCT ID: NCT03580213 Recruiting - Clinical trials for Dupuytren Disease of Palm and Finger, With Contracture

Hand Therapy or Not Following Collagenase Treatment for Dupuytren's Contracture?

Start date: April 5, 2018
Phase: N/A
Study type: Interventional

This study evaluates if hand therapy have an impact on the patients' preformance of and satisfaction with everyday activities or not following collagenase injection treatment for Dupuytren's contracture. Differences on this between patients with contracted proximal interphalangeal joint(s) and patients with affected metacarpophalangeal joint(s) only, will also be investigated. Two equal sized groups will either receive hand therapy or no treatment following the injection and extension procedure.

NCT ID: NCT03580057 Recruiting - Clinical trials for Cardiovascular Risk Factor

Effect of Weight Loss and Lactation (the EVA-trial)

EVA
Start date: January 30, 2018
Phase: N/A
Study type: Interventional

A randomized controlled trial aiming to investigate the effects and possible interactions of diet induced weight loss and lactation on cardiometabolic profile

NCT ID: NCT03579667 Recruiting - Clinical trials for Cardiovascular Risk Factor

Lipid Profile and Weight After Pregnancy

Start date: August 15, 2017
Phase: N/A
Study type: Interventional

A randomized controlled trial aiming to investigate the effects of diet behavior intervention postpartum on body weight and lipid and metabolite profile in overweight and obese women in Oslo, Norway

NCT ID: NCT03579017 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study

Start date: May 1, 2017
Phase:
Study type: Observational

Cognitive impairment is present in about 30-50% of the patients with amyotrophic lateral sclerosis (ALS). Suitable screening tools are available, but none of these are evaluated in a Norwegian population.

NCT ID: NCT03578796 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study

Start date: May 1, 2017
Phase:
Study type: Observational

This study evaluate use of a translated Norwegian version of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS-N) as an early predictor in car-driving, working and use of advanced life-prolonging therapy.

NCT ID: NCT03578484 Recruiting - Breast Cancer Clinical Trials

Breast Aesthetics by Three Dimensional Measures

Start date: May 13, 2016
Phase:
Study type: Observational

Traditionally the measures of the optimally aesthetic breast have been assumed to be static and to represent universal values (1). Measures developed for optimal aesthetic results in breast reduction were derived from brassiere patterns and then applied universally (2). These early and important papers still strongly influence the view of the aesthetics of the breast despite the lack of individualisation and proportion. To create satisfying results for specific patients, optimal proportions angles and relative measures are needed for each patient. The study will clarify theses measures and provide important guidelines for surgeons.The data will also help define optimal proportional aesthetics in the individual patient. The concept of universal beauty is unrealistic. It has always been taken for granted that aesthetic values from all cultures are similar. Using 3D scanning on volunteers of youthful age offers a complex set of data that may distinguish fine differences in aesthetic ideals in different cultures. Little is known about how life events and life-style factors affect breast aesthetics. To follow a population with 3D scans over 5, 10 and 15 years will allow aesthetic ratings to be correlated with life events such as pregnancy, childbirth, breast-feeding and life style factors such as smoking. The study will improve the understanding of breast aesthetics in general, in different cultures and in relation to life events and life style factors. No similar studies have previously been performed.

NCT ID: NCT03578380 Recruiting - Breast Cancer Clinical Trials

Supermicrosurgery for Breast Cancer Survivors With Lymphedema.

Start date: January 26, 2016
Phase: N/A
Study type: Interventional

A randomised prospective investigation of volume and quality of life results with lymphovenous anastomosis in patients with unilateral arm lymphedema after breast cancer using Indocyanine Green lymphangiography and MD Anderson Staging.

NCT ID: NCT03577847 Recruiting - Stroke Clinical Trials

Rural CT Examination and Thrombolytic Treatment for Stroke

RURALCT
Start date: November 20, 2017
Phase:
Study type: Observational [Patient Registry]

To counteract long term sequelae from stroke you need ultrarapid diagnosis and treatment, high quality multidiciplinary in-hospital care and optimal long term rehabilitation. In this study, the investigators are moving the essential first diagnosis and treatment out into the community close to where the patient lives thus shortening the all important time from debut of symptoms to thrombolytic treatment improving the prognosis of stroke patients.

NCT ID: NCT03576833 Recruiting - Obesity Clinical Trials

The BALLOON- (BALLOon Treatment for Obesity in Norway) Pilot Study

BALOON Pilot
Start date: May 15, 2018
Phase: N/A
Study type: Interventional

This protocol describes a feasibility pilot study preceding a randomized clinical study that aims at comparing the Elipse intragastric Balloon system to other invasive obesity techiniques. The current pilot study is investigating the feasibility and efficacy of the Elipse Balloon system in 20 patients in Norway.